Pilocarpine
- Generic Name
- Pilocarpine
- Brand Names
- Betoptic Pilo, Isoptocarpine, Minims Pilocarpine Nitrate, Salagen, Vuity
- Drug Type
- Small Molecule
- Chemical Formula
- C11H16N2O2
- CAS Number
- 92-13-7
- Unique Ingredient Identifier
- 01MI4Q9DI3
- Background
Pilocarpine is a cholinergic muscarinic receptor agonist.
- Indication
Pilocarpine oral tablets are indicated for the treatment of dry mouth caused by Sjogren's Syndrome or radiotherapy for cancer of the head and neck.
...
- Associated Conditions
- Acute angle-closure glaucoma, Dry Mouth, Glaucoma, Closed-Angle, Increased Intra Ocular Pressure (IOP), Narrow-angle glaucoma, Ocular Hypertension, Open Angle Glaucoma (OAG), Presbyopia, Chronic open-angle glaucoma
- Associated Therapies
- -
Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00601874
- Locations
- 🇺🇸
CEDRA Clinical Research, LLC, Austin, Texas, United States
Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2011-04-18
- Lead Sponsor
- Alberta Health services
- Target Recruit Count
- 220
- Registration Number
- NCT00168181
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath